Ilika plc signs MOU with Cirtec Medical

Ilika plc

Ilika Plc (LON:IKA), a pioneer in solid-state battery technology, has announced it has broadened its relationship with Cirtec Medical, an industry-leading strategic outsourcing partner of complex medical devices including minimally invasive and active implantable devices, by signing a memorandum of understanding which outlines the transfer of Stereax mm-scale battery manufacturing to Cirtec’s facility in Lowell, Massachusetts, U.S.

Ilika will focus on advanced technology development and IP licensing in support of Cirtec’s manufacturing and commercialisation activities. This partnership will reinforce Cirtec’s ongoing activities in system level miniaturisation for the medical device industry. Benefits of this partnership, to Ilika, include:

·    Further validation of Stereax’s capabilities

·    Manufacturing partnership delivering economy of scale and ability to rapidly ramp production

·    Expanded business development team bringing additional commercial momentum

In due course Ilika and Cirtec envisage signing a contract once the terms of the partnership have been finalised and a further announcement will be made at this time.

Graeme Purdy, Ilika Plc’s Chief Executive Officer, said: “Our partnership with Cirtec reinforces a pathway towards commercialisation of our Stereax battery technology. Cirtec brings a wealth of manufacturing experience and a strong track record of successful product commercialisation in the medical device industry.”

Brian Highley, Cirtec Medical Chief Executive Officer, commented: “With over 20 years of experience in the design, development and manufacturing of medical devices, Cirtec is uniquely poised to work with Ilika in bringing its Stereax battery technology to market. We believe this collaboration fits right into our strengths and expands upon our mission to vertically integrate our capabilities to support our offerings to the implantable and wearable device markets.”

Ilika specializes in the development of solid-state batteries. Its Stereax product line is designed for miniature medical implants and specialist internet of Things (IoT) applications. Stereax enables disruptive product designers looking for an intrinsically safe, long life (1000s recharges), low leakage (nA) and miniature power source in a rectangular form factor similar to ICs. 

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika CEO highlights Stereax revenue growth and Goliath defence interest

Ilika CEO Graeme Purdy discusses Stereax product revenue, planned M300 battery deliveries, Goliath 10Ah development, EV market trends and rising demand from the defence sector.

Ilika plc reaches a commercial turning point as new markets emerge for Stereax and Goliath (video)

Dr Tom McColm of Morphose Capital Partners explains why the company may be approaching an important commercial inflection point.

Ilika plc: Stereax Revenue Arrives as Goliath Draws Defence Interest (video)

Ilika plc CEO Graeme Purdy outlines how Stereax has started generating product-related revenue, why M300 battery deliveries remain on track and how Goliath’s 10Ah prototype is opening new opportunities in defence and sovereign battery supply.

Ilika builds commercial momentum across Stereax and Goliath batteries

Ilika Plc reports annual results for the year ended 30 April 2026, highlighting progress on its Stereax medical battery line and Goliath large-format batteries for EV, defence and consumer applications. The company began Stereax production and deliveries, shipped larger Goliath prototypes, secured further grant funding and raised £5 million post-period to accelerate commercialisation.

Defence demand puts specialist battery technology in focus

Defence applications are increasing the need for specialist batteries that can deliver reliable power in demanding operating conditions.

Battery & Energy Storage Tech Europe 2026 targets the next phase of industrial growth

Battery & Energy Storage Tech Europe 2026 will focus on financing, deployment, manufacturing, recycling and regulation across Europe’s battery market.

Search